Alax Bioresearch: Facilitating Environment For Better & Healthier Living

Manish Poriya, Director

Manish Poriya

Director

The nutritional and dietary supplements industry in India has experienced an exponential growth rate over the last ten years due to increased health con­sciousness and urban lifestyle. But this dynamic market also comes with challenges which include issues such as extreme regulatory requirements, obtaining high-grade raw materials, and addressing consumer demand for clean-label, plant-based and no-sugar products.

Further­more, manufacturers also need to address scalability, safe­ty, and traceability while keeping ahead of trends such as eco-friendly packaging and personalized formulations. These obstacles require innovative responses and strate­gic alliances to provide the relevant quality and efficacy.

Alax Bioresearch, under the direction of Director, Manish Poriya, has robustly positioned itself as a credible contract manufacturer and addresses the aforementioned challenges head-on. The company, which was established back in 2017, provides end-to-end solutions ranging from research and development to formulation and packaging and regulatory support.

With certifications such as FSSC 22000, GMP, and HACCP, the firm guarantees uncompromising quality and 100 percent traceability in the supply chain, respectively. Its state-of-the-art facilities feature automated controls and inline quality checks, allowing for flexible, client-tailored solutions.

Your Go-to Partner in Nutritional Supplements

Alax Bioresearch is a name to be reckoned with in India’s rapidly emerging nutritional supplement industry today, bringing in-depth expertise in offering end-to-end solutions to aid new ventures as well as proliferating the existing brands’ success.

From developing new formulas to manufacturing packaging and dealing with regulations, the company hand-holds clients in getting their products to market quickly and efficiently. The team leverages high-tech tools, such as automated systems and real-time quality checks to ensure production excellence.

Furthermore, the company excels at developing products that are liked by today’s consumers, clean-label, plant-based, and sugar-free supplements. Its R&D team creates vegan-friendly products, which not only taste good but also deliver results with natural, sustainable ingredients.

To maintain high quality and keep costs low, the company works with dependable suppliers from all around the world and at home for high-quality raw materials. It also monitors the entire process with a digital system of record keeping, ensuring that no trace of data is lost or missing, which complies with rigorous regulations.

We pride ourselves on being more than just a manufacturer, we are strategic partners in our clients’ growth, delivering innovative, high-quality solutions tailored to their needs

Manish Poriya, Director

When we speak of packaging, the company does not stop at the bare minimum. It offers a plethora of products which range from jars, sachets, blisters, and eco-friendly materials, and even have options to customize the products with embossed logos or metallic finishes to make the products stand out.

“We pride ourselves on being more than just a manufacturer, we are strategic partners in our clients’ growth, delivering innovative, high-quality solutions tailored to their needs”, says Manish. They have a wide range of products, from tablets to capsules to gummies to effervescent tablets, even pre-probiotic mouth melts and they are made with the same quality from trusted raw materials from such places as Germany, Japan, and the U.S.

Spearheading India’s Nutritional Supplement Boom

Alax Bioresearch has become a significant participant in India’s fast-expanding nutritional supplement industry. And, due to the growing importance living healthier lifestyles and wellness, the company has earned the reputation as the “go-to” contract manufacturer, today. Alax’s passion has been precisely built on the attitude towards steering optimal quality and innovation.

With cutting-edge resources such as automated systems and real-time quality reviews, the company produces a wide range of products. Additionally, the company’s competent research team manufactures clean-labeled plant-based sugar-free products that address the needs of modern health.

Alax Bioresearch works diligently to procure quality ingredients as it has built strong partnership with credible suppliers and ensures there is digital tracking to ensure its reliability from the first step through the final product. Furthermore, the company develops lasting relationships with clients to build innovative products with them closely. Under competition, it differentiates itself by its unfettered experience in offering best-in-class solutions.

“We focus on quality and always chase what’s new and different to stand out”, signifies Manish. This has made the firm a highly trusted name of dependability and creativity.

Shaping the Future of Nutritional Supplements

Moving forward, Alax Bioresearch has grand plans not to lag behind global trends, but to serve the consumer’s needs, and remain a leader in both the Indian and global markets. The firm is about building products that meet today’s lifestyles. They’re adding popular choices like fizzy tablets, sugar-free gummies, mouth-dissolving strips, and prebiotic mouth masks to their line.

These are products that appeal to people who want clean, plant-based, or sugar-free supplements, and are great for everyone, including teens and adults. Their research and development team is developing new formulas based on tried and tested, high-quality ingredients to make products that differentiate and work really well.

To expand its presence at the global front, the company is also improving its manufacturing capabilities by integrating future-ready technology such as automated systems and digital tracking so that all products meet the high quality and high safety standards no matter where in the world they are used by, be it in the U.S., or Korea or any other place.

It is also developing positive relations with trusted suppliers around the world to ensure they get first-class raw materials without breaking the bank.

Going forward, the company envisions becoming the most sought-after partner for brands by investing in smart technology such as automation and AI in order to make production easier and faster. The company’s goal is simple, which is to be at the forefront of the industry with unique, high-quality products that assist people in living healthier lives.

With a clear vision and the dedication to quality, the firm is ready to breakthrough and take over a permanent role. Not only do they keep up with change, they are enhancing change, and maintaining that they are a trusted name in nutritional supplements for years to come.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.